$3.36
-0.15-4.27%
Pre-Market: 6:27 PM EDT
Comments
Loading...
Grace Therapeutics (GRCE) Forecast
NewsEarningsGrace Therapeutics (GRCE) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestGrace Therapeutics (NASDAQ:GRCE) Stock Quotes, Forecast and News Summary
Grace Therapeutics Stock (NASDAQ: GRCE) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Grace Therapeutics (GRCE) stock?
You can purchase shares of Grace Therapeutics (NASDAQ:GRCE) through any online brokerage.
Who are Grace Therapeutics (GRCE) competitors?
Other companies in Grace Therapeutics’s space includes: Iterum Therapeutics (NASDAQ:ITRM), SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC), Rani Therapeutics Hldgs (NASDAQ:RANI) and Marinus Pharma (NASDAQ:MRNS).
What is the forecast, or price target, for Grace Therapeutics (GRCE) stock?
There is no analysis for Grace Therapeutics to provide a consensus price target.
What is the current price for Grace Therapeutics (GRCE)?
The stock price for Grace Therapeutics (NASDAQ: GRCE) is $3.3601 last updated February 10, 2025 at 6:27 PM EST.
Does Grace Therapeutics (GRCE) pay a dividend?
There are no upcoming dividends for Grace Therapeutics.
When is Grace Therapeutics (NASDAQ:GRCE) reporting earnings?
Grace Therapeutics’s Q3 earnings are confirmed for Tuesday, February 25, 2025.
Is Grace Therapeutics (GRCE) going to split?
There is no upcoming split for Grace Therapeutics.
What sector and industry does Grace Therapeutics (GRCE) operate in?
Grace Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.